Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Condition(s):Pervasive Development DisordersLast Updated:March 31, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Pervasive Development DisordersLast Updated:March 31, 2020Completed
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD)Last Updated:June 16, 2021Completed
Condition(s):Alzheimer DiseaseLast Updated:June 23, 2022Recruiting
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:June 28, 2021Completed
Condition(s):Cognitive AgingLast Updated:August 13, 2014Completed
Condition(s):Schizotypal Personality Disorder; SPDLast Updated:February 28, 2017Completed
Condition(s):Healthy VolunteersLast Updated:June 14, 2021Completed
Condition(s):Intermittent Explosive Disorder; Childhood Aggression; Oppositional Defiant Disorder; Attention Deficit DisorderLast Updated:June 13, 2018Completed
Condition(s):Cocaine Dependent; Alcohol DependentLast Updated:November 30, 2016Completed
Condition(s):Borderline Personality DisorderLast Updated:August 1, 2006Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.